| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 5211 |
| 1 | DUPILUMAB | 4106 |
| 2 | ADALIMUMAB | 3539 |
| 3 | TIRZEPATIDE | 1309 |
| 4 | GLATIRAMER ACETATE | 1062 |
| 5 | METHOTREXATE SODIUM | 985 |
| 6 | METHOTREXATE | 946 |
| 7 | IXEKIZUMAB | 676 |
| 8 | ERGOCALCIFEROL | 635 |
| 9 | PREDNISONE | 609 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLATIRAMER ACETATE INJECTION | 129 | 0.0274 |
| 1 | ERGOCALCIFEROL | 635 | 0.0214 |
| 2 | ANAKINRA | 335 | 0.0198 |
| 3 | IXEKIZUMAB | 676 | 0.0181 |
| 4 | GLATIRAMER ACETATE | 1062 | 0.0178 |
| 5 | GALCANEZUMAB-GNLM | 527 | 0.0163 |
| 6 | FREMANEZUMAB-VFRM | 184 | 0.0155 |
| 7 | ASFOTASE ALFA | 145 | 0.0140 |
| 8 | PEGVALIASE-PQPZ | 98 | 0.0115 |
| 9 | EXENATIDE | 479 | 0.0092 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 5579 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 4106 |
| 2 | GLP-1 Receptor Agonist [EPC] | 2589 |
| 3 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 1309 |
| 4 | Corticosteroid [EPC] | 969 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 969 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 933 |
| 7 | Interleukin-17A Antagonist [EPC] | 814 |
| 8 | Vitamin C [EPC] | 718 |
| 9 | PCSK9 Inhibitor [EPC] | 647 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 70 | 0.1017 |
| 1 | Adrenocorticotropic Hormone [EPC] | 33 | 0.0369 |
| 2 | PCSK9 Inhibitor [EPC] | 647 | 0.0251 |
| 3 | Sclerosing Agent [EPC] | 10 | 0.0222 |
| 4 | Interleukin-17A Antagonist [EPC] | 814 | 0.0218 |
| 5 | Provitamin D2 Compound [EPC] | 635 | 0.0213 |
| 6 | Melanocortin 4 Receptor Agonist [EPC] | 6 | 0.0211 |
| 7 | Interleukin-1 Receptor Antagonist [EPC] | 335 | 0.0198 |
| 8 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 145 | 0.0140 |
| 9 | Plasma Kallikrein Inhibitor [EPC] | 31 | 0.0129 |